Patient treatment preferences in unresectable/metastatic BRAF-mutated melanoma: a qualitative study

• T. Amaral,
• A. Mühlbacher,
• V. Aznar de Carrillo,
• S. Matos,
• A. Longeaud,
• E. Barbas

Affiliations

T. Amaral

Center for Dermato-oncology, Eberhard Karls University of Tübingen, Tübingen, Germany

A. Mühlbacher

Health Economics and Health Care Management, Hochschule Neubrandenburg, Neubrandenburg, Germany

V. Aznar de Carrillo

Asociación Melanoma España, Barcelona, Spain

S. Matos

Pierre Fabre Médicament, Boulogne Billancourt, France

A. Longeaud

Pierre Fabre Médicament, Boulogne Billancourt, France

E. Barbas

Asociación Melanoma España, Barcelona, Spain